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Purpose: Hydroxyapatite (HA) is a biologically active ceramic which promotes bone
growth, but it suffers from relatively weak mechanical properties. Multi-walled carbon
nanotubes (MWCNTs) have high tensile strength and a degree of stiffness that can be used
to strengthen HA; potentially improving the clinical utility of the bone implant.
Methods: HA was precipitated by the wet precipitation method in the presence of pristine
(p) or functionalised (f) MWCNTs, and polyvinyl alcohol (PVA) or hexadecyl trimethyl
ammonium bromide (HTAB) as the surfactant. The resulting composites were characterised
and the diametral tensile strength and compressive strength of the composites were mea-
sured. To determine the biocompatibility of the composites, human osteoblast cells (HOB)
were proliferated in the presence of the composites for 7 days.
Results: The study revealed that both the MWCNTs and surfactants play a crucial role in the
nucleation and growth of the HA. Composites made with f-MWCNTs were found to have
better dispersion and better interaction with the HA particles compared to composites with p-
MWCNTs. The mechanical strength was improved in all the composites compared to pure
HA composites. The biocompatibility study showed minimal LDH activity in the media
confirming that the composites were biocompatible. Similarly, the ALP activity confirmed
that the cells grown on the composites containing HTAB were comparable to the control
whereas the composites containing PVA surfactant showed significantly reduced ALP
activity.
Conclusions: The study shows that the composites made of f-MWCNTs HTAB are stronger
than pure HA composites and biocompatible making it a suitable material to study further.
Keywords: calcium phosphate, carbon nanotubes, osteoblast cells, LDH assay, alkaline
phosphatase
Introduction
A unique feature of bone is that it has apparently contradictory properties of
stiffness yet flexibility, and lightness yet strength. Bone provides mechanical sup-
port for the body and also protects the vital organs; but also enables physiological
processes such as erythropoiesis in the marrow, serves as a reservoir for minerals,
and takes part in acid–base balance.1 However, many circumstances call for bone
grafting owing to bone defects from traumatic or from non-traumatic destruction.
Synthetic nanostructured hydroxyapatite (HA) has long been an attractive choice
for the partial replacement of bone because of its similarity to the mineral compo-
nent of natural bone. Synthetic HA has shown excellent biocompatibility in vitro
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with cultured osteoblasts, as well as other cells, that read-
ily grow on HA composites or HA-coated surfaces.2
However, synthetic HA does not mimic all the mechanical,
chemical or biological properties of natural bone. A major
disadvantage of synthetic HA is its poor mechanical prop-
erties, such as brittleness and low tensile strength; thus the
clinical uses have been limited particularly in load-bearing
applications or where the section of bone replacement is
large.3 Natural HA in bone and synthetic HA also differ in
their chemical composition. Natural HA contains other
ions: mainly CO3
2− and traces of Na+, Mg2+, Fe2+,
Cl−, F−, whereas synthetic HA is usually stoichiometric,
with a chemical composition of Ca10(PO4)6(OH)2.
4
Regardless of the precise chemistry, HA plays an impor-
tant role in bone repair including osteoblast cell adhesion,
proliferation and in bone remodelling.
To overcome the mechanical problem of synthetic HA
not imparting all the desired properties of natural bone, it
has been usual to present the synthetic HA as part of a
composite material for bone replacement. Composites can
be defined as a material consisting of two or more different
components, which are combined with the aim of improv-
ing the mechanical and/or biological properties of the
overall material.5,6 Over the years, synthetic HA micro-
composites have been developed with various metals (tita-
nium, stainless steel, titanium alloys),7,8 other ceramics
(bioglass, tricalcium phosphate, alumina, zirconia)9,10 and
polymers (collagen, gelatine, chitosan, poly lactic-co-gly-
colic acid (PLGA), polylactic acid (PLA) and polymethyl
methacrylate (PMMA)). However, these composites suffer
from either very strong or very poor mechanical properties
[e.g., Stainless steel, PLGA, PLA,11,12]; induce an adverse
immune response from the host bone [e.g., Calcium
sulphate13]; or lack strong interfacial bonding between
the constituents such that the composite is not durable or
satisfactorily homogenous for clinical use.14 Recently,
with advances in nanotechnology, nanocomposites have
gained much interest and might overcome some of these
shortcomings of the micron scale composites by allowing
the manipulation of the composite constituents at the nano
level.
Nanocomposites can be defined as a heterogeneous
combination of two or more materials in which at least
one of those materials should be on a nanometer scale.5
Since natural bone has a nanoscale structure made of
several chemicals, designing bone grafts in the form of
nanocomposite is perceived to be beneficial over single-
phase and microcomposite materials. Nanocomposites are
usually made of two components; the basic matrix and the
reinforcement. In bone implants, the reinforcement serves
to improve the strength of the nanocomposite by blocking
the growth of cracks in them.15 This can be achieved by
employing materials that have a high aspect ratio. One
such reinforcement is carbon nanotubes (CNTs).
CNTs with their intrinsic properties including: a high
tensile strength (approximately ×100 times greater than
steel); high flexibility and elasticity; high electrical and
thermal conductivity and a low thermal expansion coeffi-
cient; and a high aspect ratio; is an ideal reinforcement
material.16 Therefore, in the case of HA-CNTs nanocom-
posites, a synthetic HA matrix reinforced with CNTs can
be anticipated to be biocompatible and strong.
There are many reports on the development of HA
matrix composites reinforced with multi-walled carbon
nanotubes (MWCNTs) as reviewed by Lahiri et al,17 and
Shin et al.18 Previous studies focussed on the HA matrix
composites reinforced with MWCNTs through various
processes such as sol–gel precipitation, spark plasma
deposition or ball milling.19,20 It was found that the addi-
tion of CNTs does improve the mechanical strength of the
HA composites but requires further improvement for load-
bearing devices. The dispersion of CNTs has a significant
effect on the mechanical properties. Most researchers used
functionalised CNTs with strong acids or surfactants21,22
to obtain a homogenous dispersion of the CNTs in the
matrix. The surface modifications of CNTs also have a
significant effect on the subsequent nucleation and growth
of HA crystals during the sol–gel precipitation process.
However, there are few reports on the interplay of surface
modifications and surfactants on the mechanical proper-
ties. In addition, controversy exists on the biocompatibility
of the CNTs. Some studies have reported that CNTs
increase the adhesion and proliferation of osteoblasts and
fibroblasts,19,23,24 although the biocompatibility with these
cells may depend on the diameter and surface energy of
the CNTs. In contrast, CNTs have also been reported to
reduce the proliferation of osteoblast cells and are toxic to
them.25–28 Hence, although CNTs have remarkable proper-
ties, their application in nanocomposites for bone implants
is still uncertain owing to the difficulty in obtaining a
homogenous composite that would be durable and clini-
cally robust, as well as disagreement on biocompatibility
of the composites, especially for bone cells.
The overall aims of the current study were therefore to
provide a HA-MWCNTcomposite that would be acceptable,
in principal, for clinical use. Initial experiments explored the
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best approaches to preparing a homogeneous composite by
using functionalised and pristine MWCNTs and various dis-
persing agents to explore nucleation of the HA and growth of
the composite. Then, after testing the resulting composites
for their mechanical properties, the best materials were
selected for biocompatibility studies. These latter experi-
ments explored cell health in vitro using cultured human
osteoblasts (HOB) cells.
Materials And Methods
In order to study the effect of MWCNTs in synthetic HA
nanocomposites, 4 different types of nanocomposite pow-
ders were produced using pristine (p, as produced) and
functionalised (f, oxidised with Nitric acid) MWCNTs
with two types of surfactants – polyvinyl alcohol (PVA)
and hexadecyl trimethyl ammonium bromide (HTAB), in
combinations as follows: 1. p-MWCNTs-PVA, (HA + pris-
tine MWCNTs + PVA); 2. f-MWCNTs-PVA, (HA + func-
tionalized MWCNTs + PVA); 3. p-MWCNTs-HTAB,
(HA + pristine MWCNTs + HTAB); 4. f-MWCNTs-
HTAB, (HA + functionalized MWCNTs + HTAB). Pure
HA powder (without the presence of MWCNTs or surfac-
tants) was produced in house and used as a control. The
nanocomposite powders were then mixed with PVA, or
HTAB as appropriate, to produce the final composites.
Analytical grade reagents were used throughout the produc-
tion process.
Functionalization Of MWCNTs
MWCNTs were functionalised to improve their dispersivity in
aqueous media and to compare against the pristine (not func-
tionalised) nanotubes. Commercially supplied MWCNTs
(Shenzhen Nanotech Port, China) with a diameter of 10–30
nm, length 5–15 μm and ≥95% purity (manufacturer’s infor-
mation) were functionalised in house using concentrated nitric
acid (Sigma Aldrich, UK) following an established protocol.29
Briefly, 0.3 g of the as-received MWCNTs was mixed with
25 mL of 14.5 mol/L concentrated nitric acid and refluxed at
room temperature for 48 hrs. The resulting dispersionwas then
filtered through a whatman® glass microfiber filter paper
(WHA1827070, Sigma Aldrich, Irvine, UK) with pore size
1.5 µm and washed in deionised water until neutral pH was
achieved. The sample was then dried in a vacuum oven
(Edwards High Vacuum Ltd, Crawley, Sussex) at 40°C for
24 hrs. Where measurements could be made using TEM, the
pristine MWCNTs had a length ranging between 2 and 10 μm
and diameters between 19 and 25 nm. The functionalised
MWCNTs in comparison were less tangled, and the tubes
had a curled appearance (Figure S1). The functionalised
MWCNTs were fragmented compared to the pristine material,
with lengths between 0.8 −2 μm and diameters of 13–24 nm.
Preparation Of HA-MWCNTs Powder
The various HA-MWCNT nanocomposites were prepared
using the sol–gel technique. To produce the nanocompo-
site powders, HA must be nucleated on the walls of the
MWCNTs in the presence of the surfactant. In a typical
experiment, to produce 10 g of the nanocomposite powder,
0.005 g of PVA (MW- 70,000–100,000, Sigma Aldrich,
UK) or 0.005 g of HTAB (Sigma Aldrich, UK) was added
to 100 mL ultrapure water. Then, 0.05 g of pristine or
functionalized MWCNTs was added to the mixture which
was sonicated at 50–60 Hz (Metason 120T, Struers, UK)
for 30 mins at room temperature until all the MWCNTs
were dispersed. HA was nucleated into the dispersion by
the addition of 200 mL of 0.1 mol/L calcium acetate and
0.06 mol/L of ammonium phosphate to obtain a final
calcium: phosphate ratio of 10:6, normally expressed as
1.67. The reaction occurs as follows:
5Ca (CH3COO)2·H2O + 3(NH4)2H2PO4→Ca5 (PO4)3
(OH) + 3NH4 (CH3CO2) + 7CH3CO2H
The solution was stirred at the rate of 900–1000 rpm
using a magnetic stirrer (dial setting 9, Hotplate/stirrer,
RCT basic, IKA Oxford, UK). While stirring, the pH of
the solution was checked periodically and maintained at
9.5–10 by the addition of 6 mol/L sodium hydroxide
solution. The solution was stirred for 1 hr and left to
mature for 24 hrs at 40°C. The resulting dispersion con-
taining the HA nucleated on the MWCNTs was then
filtered through a Whatman® filter paper (WHA1001070,
Sigma Aldrich, Irvine, UK) with a pore size of 11 µm. The
precipitate collected was washed with ultrapure water and
subsequently dried under a vacuum at 60°C for 24 hrs. The
dry precipitate was manually crushed with a glass pestle
and mortar to make a fine powder, and was then sintered at
100°C for 8 hrs. In order to obtain HA alone, the process
was conducted exactly as above, but without the addition
of the MWCNTs.
HA-MWCNTs Composites
The nanocomposite powders obtained from the above
method were used to prepare the final composites which
were produced following an established protocol in our
laboratory.30 Briefly, 1 g of the calcined nanocomposite
powder was mixed with 1 mL of 20% PVA at room
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temperature. The mixture was packed into cylindrical
moulds. Different sizes of moulds were used for mechan-
ical and biocompatibility test; to comply with the interna-
tional testing standards on mechanical testing (see below)
and to ensure that the composites fitted in 24 well plates
for cell culture work, respectively. The ends of the moulds
were blocked with short aluminium cylinders and then
pressure was applied on top of the cylinders using
mechanical mini pellet press (GS03940, Specac, UK).
The pressure applied on each sample was 26 MPa, which
was held for 1 min; then the aluminium cylinders were
removed from the moulds. The samples were placed in an
oven at 40°C for 48 hrs to dry the composite. Afterwards,
the samples were carefully removed from the moulds and
stored at room temperature, until required for mechanical
testing and biocompatibility studies (see below)
Characterisation Of The Composite
Materials
Physico-chemical characterisation was performed at sev-
eral steps in the synthesis of the composites including; the
original materials and their functionalised forms in disper-
sions, as well as the resulting powers that were subse-
quently compressed into pellets to make the final
composite. In addition to the manufacturer’s information,
the materials were examined by electron microscopy for
their appearance and primary size. X-ray diffraction
(XRD) is the most common technique to determine crystal
structures and atomic spacing; and was used to identify the
phase purity of the produced nanocomposite powders.
Fourier transform infrared spectroscopy (FTIR) analysis
was performed to detect the functional groups and to
characterise covalent bonding.
To confirm the primary dimensions (length, tube dia-
meter) and morphology (straightness, branches and bun-
dles), the MWCNTs as supplied by the manufacturer were
examined by transmission electron microscopy (TEM).
Batches of the functionalized MWCNTs prior to making
the nanocomposite powder were also examined; followed
by the nanocomposite powders, especially for morphology
of the HA crystal. Briefly, in separate runs, approximately
0.05 g of the material to be analysed (pristine MWCNTs,
functionalised MWCNTs and nanocomposite powders)
were dispersed separately in distilled water and sonicated
for 5 mins to create a stock dispersion. All electron micro-
scope observations were made on 3 sub-samples of each
stock. A drop of the relevant dispersion was placed on a
copper grid, then air dried, and subsequently observed at
an accelerating voltage of 120 kV using a high resolution
transmission electron microscope (TEM, JEOL 1400,
JEOL ltd, Japan). On each specimen, 30 random images
were collected for quantification of dimensions of the
materials. The images were processed using image J soft-
ware (Windows version 1.48) to measure the length and
diameter of the tubes. The same process was used to
analyse the shape, size and growth of the HA crystals
around MWCNTs powder.
Slight changes in the Ca:P ratio of the reaction mixture
and/or sintering temperature during the production of
nanocomposite powders can yield other types of calcium
phosphates such as tri- and tetra-calcium phosphate.
Hence, the phase purity of the sintered nanocomposite
powders was determined by XRD. The patterns were
obtained by an automated Philips powder diffractometer.
Briefly, each specimen was irradiated using copper anode
K (alpha) X-ray (CuKα, wavelength 1.5418 Å) generated
by 45 kV and 40 mA of current in the cathode-ray source.
All data were collected in a 2ϴ scan mode in the range of
20–40° using a step width of 0.03 Å and a 1 sec count time
(see31 for discussion of XRD parameters).
The quality of the materials was also examined by
FTIR. Briefly, FTIR involves shining a beam of light that
contains many frequencies at the specimen, and then deter-
mining which frequencies are absorbed by the specimen.
The pattern of the absorbed frequencies is characteristic of
the molecular structure of the specimen (review,32). FTIR
was used to especially determine the functional groups in
the nanocomposite powders and the final composites
which were measured for every new batch that was pro-
duced. A Bruker αP FTIR spectrometer (Bruker, UK) was
used for the measurements in attenuated total reflection
(ATR) mode with an ATR accessory utilizing diamond
prism. Spectra were recorded using small amount
(approximately 2–5 mg) of each sample (starting powders
and the final composites), enough to cover the prism. The
prepared nanocomposite powders did not require further
processing, whereas the final composites were ground in a
glass pestle and mortar to obtain a fine powder. Each
spectrum was the result of 16 accumulated scans at 4
cm−1 resolution on the same sample.
Mechanical Testing
Mechanical tests were performed to determine the tensile
and compressive strength (CS) of the produced compo-
sites. To determine the tensile strength, the diametral
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tensile strength (DTS) method was used. Diametral tensile
strength is a property described by the American National
Standards Institute (ANSI) for characterizing dental com-
posites. For each material, five replicates of the final
composites were prepared as explained in the
“HA-MWCNTs composites” section to evaluate CS and
DTS. The dimensions of the composites were 6.0 mm
diameter × 12.0 mm height for the CS test and 6.0 mm
diameter × 3.0 mm height for the DTS test. The specimens
were tested under compressive load in a universal testing
machine (3300 single column Instron, UK) at a crosshead
speed of 1.0 mm/min for CS and 0.5 mm/min for the DTS
test. For the CS test, the specimens were placed in a
vertical position, with the force incident on the long axis
of the specimen. For the DTS measurements, load was
applied vertically on the lateral portion of the cylinder,
producing tensile stress perpendicular to the vertical plane
passing through the centre of the specimen.33 The DTS
was calculated as follows:
DTS ¼ 2F=πdh
where F is the load applied; d is the diameter of the
composite; h is the height of the composite; π = 3.14
(constant).
Experimental Design And Preparation Of
The In Vitro Study
In vitro cultures of human osteoblasts were used to
demonstrate the biocompatibility of the finished compo-
sites. Human osteoblast cells (406-05A; Sigma Aldrich,
UK) were grown in Dulbecco’s modified eagle medium
(DMEM; product number 11530596; Thermo Fisher scien-
tific, Loughborough, UK) supplemented with 10% Fetal
bovine serum (FBS, product number 11563397; Thermo
Fisher scientific, Loughborough, UK) and 1% Antibiotic-
antimycotic (contains penicillin, streptomycin and Gibco
Amphotericin B; product number 15240–096; Thermo
Fisher scientific, Loughborough, UK), referred to hereafter
as “DMEM”. Cells were sub-cultured in 25 cm2 cell cul-
ture flasks until the required amount were available.
The experimental design involved exposing the osteo-
blast cells to the composites. Before exposing the cells, the
composites were sterilized using Gamma radiation (dosage:
36.42–40.72). Then, using Sterile forceps, the sterile com-
posites (d = 15mm) were carefully placed at the bottom of
24 well plate (flat bottom sterile, tissue culture treated
polystyrene microplate; 662,160, Greiner bio-one,
Stonehouse, UK). The cell culture plate containing all the
controls and treatments, and was the unit of replication in
the study design. Composites made of pure HA served as a
positive control, while HOB cells grown in wells without
the presence of any composites served as negative controls
on each cell culture plate. In addition to these controls, the
treatments were: p-MWCNTs-PVA, f-MWCNTs-PVA,
p-MWCNTs-HTAB, f-MWCNTs-HTAB. Since the unit of
replication was the cell culture plate with each plate con-
tained all the materials and controls, a total of nine plates
were prepared to give n = 9 replicates. To ensure the cells
used were representative, the experiments were repeated on
three separate days with different aliquots of cells from the
stock cultures (i.e., triplicate runs of triplicate plates with all
material to make nine replicates). Each well was seeded
with 1.2×104 cells/well and the microplates were incubated
for seven days at 37°C under 5% CO2 in atmospheric air to
allow the cells to grow. The DMEM media was changed at
24 and 96 hrs to ensure the culture conditions were not
limiting. Changes in pH and presence of lactate dehydro-
genase activity (LDH) were measured from the collected
media at the three time points (1st, 4th and 7th day). In
addition, six of the replicate plates were used to make cell
homogenates for biochemistry and three plates were left
intact for electron microscope observation on the cells
(see below).
For biochemistry, cell homogenates were prepared in
hypo-osmotic buffer at the end of the experiment according
to Gitrowski et al34. Briefly, cells were carefully washed twice
with 2 mL of isosmotic sucrose buffer (300 mmol/L sucrose,
0.1 mmol/L ethylenediaminetetraacetic acid (EDTA), 20
mmol/L 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
(HEPES), buffered to pH 7.4 with a few drops of 2 mol/L
Trizma base). The cells attached to each composite were then
treated with 1 mL of a lysis buffer (hypo-osmotic version of
the buffer above consisting of 30 mmol/L of sucrose). The
lysis buffer containing the cell homogenate was sonicated for
30 s to ensure the lysed sample was mixed well. Fresh aliquots
of the cell homogenate were used for the assessment of LDH,
alkaline phosphatase activity (ALP), the protein content and
the electrolyte composition (Na+, K+, Ca2+, P+ and Mg2+) of
the cells.
Biochemical Indicators Of Cell Health
The presence of lactate dehydrogenase activity in the
external media (DMEM) was used to assess the viability
of the cells in terms of membrane integrity (i.e., membrane
leak of this normally cytosolic enzyme). In addition, the
LDH activity in the cell homogenates was also measured
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to indicate the metabolic status of the cells. Briefly, LDH
activity was measured according to Campbell et al,35 with
minor modification. The collected DMEM, and cell homo-
genates, were gently centrifuged for 1 min at approxi-
mately 13,000 ×g (Heraeus pico 17 centrifuge, Thermo
electron crop, UK) to remove debris. Then, 100 μL of the
supernatant from each sample was added to 2.9 mL of a
reaction mixture consisting of 2800 μL of 6 mmol/L
pyruvate in 50 mmol/L of phosphate buffer (pH 7.4) and
100 μL of 6 mmol/L nicotinamide adenine dinucleotide
(NADH, Melford Laboratories Ltd, Suffolk, UK), directly
in a 3 mL cuvette. The change in absorbance was mea-
sured immediately over 2 mins at 340 nm (Helios β
Spectrophotometer, UK). LDH activity was calculated
using the extinction coefficient of NADH at 340 nm of
6.3 mmol/L and a 1 cm path length. The cell homogenate
LDH was normalized with the homogenate protein
content.
The total protein content in cell homogenates was
measured using the Pierce BCA protein assay kit
(Product number: 23227, Thermo Fisher scientific,
Loughborough UK). The assay was performed according
to the manufacturer’s instructions. Briefly, a working
reagent was prepared by mixing reagents A and B in a
50:1 ratio. Twenty μL of the cell homogenate (in triplicate)
was transferred to a 96-well microplate, to which 200 μL
of the working reagent was added and carefully mixed.
Plates were covered and incubated at 37°C for 30 mins and
absorbances were read at 562 nm on microplate reader
(OptiMax Tunable microplate reader, Molecular devices,
UK) against bovine serum albumin protein standards.
Alkaline phosphatase activity in the homogenates was
also measured. This enzyme is involved in the calcification
of bone and is therefore of functional significance to
osteoblasts as developing bone cells. Alkaline phosphatase
activity is, therefore, useful to assess the health and func-
tionality of osteoblast. The activity of alkaline phosphatase
enzyme was measured using a colorimetric assay based on
the hydrolysis of para-nitrophenylphosphate (pNPP) to
p-nitrophenol (PNP), a yellow-coloured substrate.36
Briefly, 65 μL of the cell homogenate was added to 595
μL of the reagent assay (265 μL of 0.1 mol/L glycine
buffer + 330 μL of 0.5 mmol/L pNPP in glycine buffer).
The appearance of p-nitrophenol was measured spectro-
photometrically at 405 nm (Helios β Spectrophotometer,
Thermo scientific, England). ALP activity was calculated
using an extinction coefficient of 18.3 mmol/L for a path
length of 1 cm. The cell homogenate ALP activity was
normalized with cell protein content as above.
Electrolytes In The Culture Media And Cell
Homogenates
The total concentration of Na+, K+, Ca2+, P and Mg2+ was
determined in the DMEMmedia after 1, 4 and 7 days, and in
the cell homogenates at the end of the experiment. The
electrolyte measurements were made in the context of the
osmotic health (ie, electrolytes involved in cell volume con-
trol and integrity of the cells), as well to inform on the
presence of the minerals needed for bone formation. For
electrolyte analysis, 400 µL of the external media from
each well was acidified with 20 µL of 70% nitric acid. For
the cell homogenate, 800 µL from each sample was taken
and acid digested with 1 mL of 70% nitric acid and left
overnight for complete acid digestion. Then, Na+, K+ and
Ca2+ P and Mg2+ of each sample were determined using
inductively coupled plasma optical emission spectroscopy
(ICP-OES, iCAP 7400 RADIAL, Hemel Hempstead, UK)
against matrix-matched standards. Sample runs included
blanks to correct for instrument drift and procedural blanks
to correct for background metal concentrations. The concen-
tration of electrolytes was expressed as mmol/L in the media,
and as µmol/mg cell protein in the cell homogenates.
Cell Morphology
Morphology (shape and appearance) of the cells was reg-
ularly observed by light microscope to determine the
health of the cells. The DMEM media appeared normal
with no loss of the pH indicator or excessive cell debris.
Light microscopy observations showed no signs of dete-
rioration of the cells such as; necrosis, detachment of cells
from the substrate, granularity around the nucleus or
obvious disruption of the cell membrane (i.e., no mem-
brane blebs or cell swelling). At the end of the experiment,
the presence and health of the cells were determined using
a scanning electron microscope (SEM, JEOL JSM
−5600LV, JEOL ltd, Japan). For logistical reasons, a sepa-
rate run (n = 3 replicates) was done for the SEM work.
After the media was removed, samples were washed twice
with phosphate-buffered saline (PBS) and fixed using
2.5% glutaraldehyde in 0.05 mol/L cacodylate buffer at
pH 7.4 for 2 hrs. Fixed samples were dehydrated through a
series of ethanol and then critical point dried. Samples
were mounted on conducting carbon stubs and coated
with gold in a sputter coater (EMITECH K550, Quorum
Technologies, UK). SEM images were collected using a 15
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kV accelerating voltage. The observations were conducted
systematically, starting at a lower magnification (×30) to
examine the distribution of the cells on the composites,
and then at a higher magnification (×1000) to observe the
morphology of the cell membrane, organelles and nucleus
as well as to determine the attachment of cells on the
composites.
Statistics
All data are presented as mean  standard error and were
analysed using statgraphics software for windows (version
XVI.I). After descriptive statistics to determine normality,
skewness or kurtosis, parametric data were analysed by
ANOVA. Briefly, after a variance check (Levene’s test)
and one-way ANOVAwas conducted followed by Tukey’s
multiple range test to identify the locations of any differ-
ences. The differences between the treatments and controls
at each time point, and time effects within treatment were
evaluated using one-way analysis of variance (ANOVA).
Non- parametric data were analysed by the Kruskal–Wallis
test. For treatment × time effects, a two-way ANOVA was
also applied to the data. All statistical analysis used the
default 95% confidence limit for statistical significance.
Results
Physico-Chemical Characterization Of
The Dispersed Powders And Final
Composites
The prepared dispersions of each of the nanocomposite
powders were examined for morphology by electron micro-
scopy and characterised by XRD and FTIR. In addition, the
final composites which were made by mixing the powders
with PVA and compressed into pellets were also studied by
FTIR. TEM analysis (Figure 1) of the nanocomposite pow-
ders dried from the stock dispersions shows the presence of
nano HA in all the samples. The HA crystals exhibited the
typical needle-like morphology as expected in the pure HA
control, p-MWCNTs-PVA and f-MWCNTs-PVA nanocom-
posite powders (Figure 1A–C, respectively). The crystal
structure of nanocomposite powders made in the presence
of HTAB surfactant (p-MWCNTs-HTAB and f-MWCNTs-
HTAB; Figure 1D and E) show short nano-rod like struc-
tures. The difference in length of the overall powder
rod-like HA structure is detailed in Table 1 with the pure
HA powder exhibiting maximum size and the powders
containing HTAB surfactant exhibiting the least size.
Figure 1 shows that, in all the treatments, the HA had
nucleated and grown around the MWCNTs.
XRD analysis was performed to determine the crystal
structure and phase purity of the HA in the nanocomposite
powders during the TEM work. The XRD spectrums of the
powders are shown (Figure 2). The data obtained from
XRD are consistent with the morphology observed in the
TEM images, which indicates that the HA phase was
produced in all the samples. Broad diffraction peaks
were observed in all the nanocomposite powders, indicat-
ing the presence of nanocrystals.
FTIR spectroscopy is an effective tool for determining
the presence of functional groups. Figure 3 represents the
FTIR absorption peaks of the prepared nanocomposite
Figure 1 Representative transmission electron microscopy images of stock disper-
sions of the prepared composite powders depicting the difference in HA particle
structure and interaction with the CNTs (n = 3 samples/treatment for each batch);
(A) Pure HA crystals; (B) p-MWCNTs-PVA; (C) f-MWCNTs-PVA; (D) p-
MWCNTs-HTAB; (E) f-MWCNTs-HTAB; (F) p-MWCNTs-HTAB (closer observa-
tion). In panel (A), the arrows point to the appearance of needle-shaped particles;
in panels (B–D) the arrows point to the interaction between the HA and the
CNTs. Note, in panel (B) the clusters of needle like HA surrounding the CNTs. In
panel (D, E), the growth of HA crystal and the CNTs shows that the crystals have
not obtained the needle structure, but have a rod shape (F).
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powders and the final composites. All the major charac-
teristic bands of HA are observed in all the nanocompo-
site powders as shown in Figure 3A. Additionally, a peak
at 2917 cm−1 was observed in all the powders, except the
pure HA. This is due to C–H bond which is expected
from the presence of MWCNTs. The intensity of the
peaks suggests a chemisorption nature of the bond.
FTIR analysis of the final composites (Figure 3B)
shows that all the peaks present in the powders exist in
the composites. However, the peak corresponding to the
MWCNTs was not visible above the background, and this
is not surprising given the µg amounts of MWCNTs in
the composites. An important peak was verified at 1141
cm−1 that is attributed to the crystallinity of the PVA. The
peaks corresponding to PVA (reference spectra) were
observed in all the composites.
The tensile and compressive strength test results of the
pure HA nanocomposite (control) and all the final compo-
site treatments (p-MWCNTs-PVA, f-MWCNTs-PVA,
p-MWCNTs-HTAB and f-MWCNTs-HTAB) after 48 hrs
curing are presented in Table 2. The tensile strength of all
the final composites was significantly higher than pure HA
composites. There was also a significant difference in the
tensile strength between all the composites. The maximum
tensile strength was observed in the composite made of
p-MWCNTS-PVA which was an increase of 215% com-
pared to the pure HA composite. The least tensile strength
among the composites containing MWCNTs was observed
Table 1 Average HA Crystal Size Of The Prepared
Nanocomposite Powders*
Composite Powder Average HA Crystal Size (nm)
HA (Control) 130.12 ± 12 a
p-MWCNTs-PVA 87.16 ± 36 b
f-MWCNTs-PVA 80.6 ± 22 b
p-MWCNTs-HTAB 62.6 ± 18 c
f-MWCNTs-HTAB 52.4 ± 13 d
Notes: *The data represent mean ± S.E.M (n = 20 measurements per composite
powder). TEM images were processed through Image J software to obtain the
measurements. Different letters a, b, c, d represent statistical difference
(ANOVA, P <0.05) between the nanocomposite powders.
Figure 2 X-Ray Diffraction analysis of the nanocomposite powders dried from the
stock dispersions prepared for transmission electron microscopy. (A) XRD peaks
data for a HA certified reference material from the ICDD no. 9–432;50 (B) XRD
analysis of the powders: i) Pure HA control; ii) p-MWCNTs-PVA; iii) f-MWCNTs-
PVA; iv) p-MWCNTs-HTAB; v) f-MWCNTs-HTAB. The peaks observed in the
powders correspond to the reference HA sample from the ICDD. The spectra
lines are from triplicate measurement on two batches.
Figure 3 (A) Fourier Transform Infrared Spectroscopy analysis of the prepared
powders and (B) the final composites. i) Pure HA control; ii) p-MWCNTs-PVA; iii)
f-MWCNTs-PVA; iv) p-MWCNTs-HTAB; v) f-MWCNTs-HTAB; vi) PVA (refer-
ence). Arrows point to the absorbance peaks for the functional groups present in
the powders and the composites. The spectra lines are from triplicate measure-
ment on two batches.
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in the p-MWCNTs-HTAB, which was 49% less than the p-
MWCNTS-PVA composite. The maximum compressive
strength was also observed from the composite made of
p-MWCNTs-PVA, which was significantly higher than the
other composites. This was an increase of 100% compared
to the pure HA composite. Unlike tensile strength, no
significant difference in compressive strength was
observed between the composites containing HTAB sur-
factant, but they were significantly lower compared to the
composites containing PVA.
Morphology And Health Of Cultured Cells
Light microscopy was used to visually monitor cell health
during the experiment. The cultured wells after 24 hrs
showed no evidence of cell debris, no detachment of cells
from the substrate or gross changes in morphology. Routine
light microscopy during the rest of the experiment showed
cells with normal morphology and with intact cell mem-
branes. The pH of the cell culture media also remained
circumneutral, with only a slight acidity (pH 6.8) in the
first 24 hrs in the HA and p-MWCNTs-PVA treatments
that was quickly corrected at the first media change and
remained neutral thereafter. The average pH of the media
over the seven days were: media (no cells), 7.7 ± 0.02; blank
(cells in DMEM), 7.80 ± 0.03; HA, 7.20 ± 0.05;
p-MWCNTs-PVA, 7.12 ± 0.13; f-MWCNTs-PVA, 7.34 ±
0.06; p-MWCNTs-HTAB, 7.41 ± 0.03; f-MWCNTs-HTAB,
7.34 ± 0.03. At the end of the experiments, cells were
observed in more detail by SEM (Figure 4). After seven
days, the cells displayed a typical osteoblast morphology
with regular cell structures in the controls and the treat-
ments. No obvious morphological differences were
observed between the cells maintained on the various treat-
ments (Figure 4). The cells had intact homogenous
cytoplasm and were attached and flattened on the substrate
surface. In all the treatments, the cells spread to cover
essentially all available regions of the dish. Since the treat-
ments were on uneven surfaces, the cells were often seen to
form bridges between the gaps, as expected for healthy
osteoblasts.
Cell health was also confirmed biochemically by the
absence of progressive LDH leak into the external media,
with LDH in the media remaining at a background level
(<0.1 µmol/min/L, Figure 5). The LDH activity in the cell
homogenates was also modest, and although there were some
statistical differences between treatments (Figure 5), the LDH
activity remained <1 µmol/min/mg protein with no evidence
of induction of anaerobic metabolism by the cells. There was
also no evidence of osmotic disturbances in the cells with no
differences amongst the treatments in the bulk electrolytes
(Na+, K+) within the cells (Table 3). The presence of alkaline
phosphatase activity in the cell homogenate was used as a
measure of metabolically active osteoblast cells (Figure 5). At
the end of the experiment, all treatments showed the presence
of alkaline phosphatase activity, and although there were some
differences between treatments, the activity remained below
0.1 µmol/min/mg protein (Figure 5).
Discussion
This study reports the synthesis ofMWCNTs reinforced HA
composites and the effect of MWCNTs and surfactants on
the overall biocompatibility and mechanical properties of
the composites. Overall, the data confirm that reinforcing
HAwith MWCNTs improves the mechanical properties of
the composites significantly; the addition of surfactants
plays a major role in the formation of HA crystals, and the
subsequent strength of the HA–MWCNTs composites has
at least doubled, compared to the control. The biocompat-
ibility study demonstrated cells with healthy morphology,
with no evidence of LDH leak and the capability to produce
ALP activity.
HA Crystal Nucleation And Growth In
The Presence Of MWCNTs
The TEM images (Figure 1) demonstrate that HA-MWCNTs
nanocomposite was successfully synthesized. However, a dif-
ference in the growth of HA on the sidewalls of pristine and
functionalized MWCNTs was observed. Relatively higher
amount of HA interaction was observed with functionalised
MWCNTs compared to pristine MWCNTs. This is due to the
fact that functionalising CNTs with nitric acid creates negative
Table 2 Comparison Of The Tensile And Compressive Strength





HA (Control) 2.6±0.12 a 15.1 ± 0.47 a
p-MWCNTs-PVA 8.2±0.16 * b 30.3±0.20 *b
f-MWCNTs-PVA 6.3±0.13 *c 25.7±3.38 *c
p-MWCNTs-HTAB 5.5±0.38 *d 21.4±1.68 *c
f-MWCNTs-HTAB 6.7±0.23 *c 22.2±3.38 *c
Notes: **Mechanical strength of the composites after curing for 48 hrs. The data
represent mean ± S.E.M (n= 5 per composite for each test). *Statistically different
from the control (pure HA composite). Within each test, different letters a, b, c
represent statistical difference between the composites (ANOVA, P <0.05).
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charge (–COO−) on the sidewalls of the CNTs which acts as
nucleation sites for HA. The Ca2+ ions get attracted to the
negative charge allowing the growth of HA on functionalised
CNTs. Similarly, the presence of surfactants (PVA and HTAB)
also influences the nucleation and growth of HA.
Preliminary trials on the synthesis of HA in the presence of
MWCNTs without surfactants were not successful at produ-
cing HA at all (not reported here); but the procedure was
achieved with the additions of either PVA or HTAB
(Figure 1). The synthesis is, therefore, best achieved in the
Figure 4 Scanning electron microscopy images of the osteoblasts in various magnifications. (A) Control cells grown on the plastic plate; (B) cells grown on pure HA as a
control. It can be seen that the cells have infiltrated into the pores; (C) shows cells grown on p-MWCNTs-PVA; (D) shows cells on f-MWCNTs-PVA, note that the cells are
flat and extending to cover large surfaces of the substratum; (E) shows cells on p-MWCNTs-HTAB; (F) shows cells on f-MWCNTs-HTAB. The arrows show the presence
of the cells on the composites.
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presence of dispersing agent. Of these surfactants, PVA is the
preferred choice as only HA synthesised in the presence of
PVA produced nano-HA crystals that were the expected nee-
dle shaped. Critically, the needle-like morphology of the HA
(Figure 1) is consistent with the HA crystals in human bone.37
The needle-like morphology of HA in the presence of PVA
could be explained by ligand chemistry. The Ca2+ ions from
the additions of calcium acetate likely electrostatically bind to
the OH− groups on the PVA polymer forming a –OH-Ca+
moiety (ie, a net positive charge on the surface of the PVA)
which is then capable of attracting PO4
3− ions from the sub-
sequent additions of ammonium phosphate. Thus, the PVA
regulates the growth of the HA crystals along the c-axis of the
polymer giving the crystals the needle structure.38,39 In the
present study, the biocompatibility of the dispersants was also
a consideration and a low concentration of PVA was chosen
for the study (0.05 wt%). This low concentration of PVA
enabled nucleation of the HA to occur with the expected
needle-like morphology. Interestingly, Rajkumar et al, have
reported that if the concentration of PVA in the solution is
increased by 2.5 wt%, it results in the formation of crystals
with irregular structures combined with a reduction of the
crystal size.38
In contrast to PVA, HTAB being an organic cationic
surfactant does aid the dispersion of the MWCNTs in the
mixture; but does not promote nucleation. This is because
HTAB is positively charged like the Ca2+ involved in the
nucleating HA, and will therefore cause a coulombic
repulsion.40 Hence, the interaction of the surfactant and
HA is weaker compared to that of PVA. However, the
absorption density of HTAB on HA is higher compared to
anionic surfactants due to the lateral mobility of HTAB.
Owing to the higher absorption density of HTAB and the
presence of coulombic repulsion, small HA particles are
more stable in aqueous solution as observed. However, the
presence of PVA or HTAB in the HA-MWCNTs powders
cannot be verified using XRD and FTIR due to the minus-
cule amount being used during the synthesis process.
Factors Contributing To The Mechanical
Properties
The main purpose of synthesizing the HA-MWCNTs com-
posites is to improve the mechanical properties of syn-
thetic HA. Significant increase in both tensile and
compressive strength of the composites containing
MWCNTs was observed compared to control (pure HA)
(Table 2). This is due to the interfacial bonding between
the HA and the MWCNTs. However, variation in both
tensile and compressive strength can be observed between
the composites containing MWCNTs. Although literature
suggests that functionalisation of MWCNTs improves their
wettability which in turn enables the interaction with the
HA particles,20 composites containing f-MWCNTs have
not exhibited the maximum tensile or compressive
strength. This could be explained by the fact that the acidic
Figure 5 LDH and ALP activity release from osteoblast cells after 7 days of growth
in DMEM on culture plate. (A) LDH activity released into the media, and the cell
homogenate LDH activity for all the treatments and the control. (B) Alkaline
phosphatase (ALP) activity from cell homogenates. Data are mean ± S.E.M (n = 6),
bars with “*” indicate statistical significance and the different letter a, b, c, d
indicates statistical difference from each other (one-way ANOVA, P <0.05).
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oxidative treatment causes major alteration to the struc-
tural properties of the CNTs. Garg et al, developed a
simulation model to predict the effect of acid treatment
on the mechanical properties of CNTs. They have showed
that acid treatment introduces carbon defects that degrade
the mechanical strength of CNTs by an average value of
15%.41 Composites made of p-MWCNTs-PVA have
shown the maximum tensile and compressive strength
(Table 2). There are two factors contributing toward the
higher mechanical properties with pristine MWCNTs. The
absence of defective sites in the sidewalls of the MWCNTs
contributes to the overall strength of the final composite.
The HA particles are significantly longer with a needle
shape which contributes to the improved mechanical prop-
erties of p-MWCNTs-PVA composites. However, while
comparing the interaction of HA particles with
MWCNTs (Figure 1) to the mechanical strength of the
composites (Table 2), it appears that there is no direct
correlation between the two, since, composites containing
f–MWCNTs show high degree of interaction with HA
particles.
Effects Of Composites On DMEM Media
And Cell Health
The pH and electrolyte concentrations were measured in
the external media for several reasons. Firstly it is to
confirm that the presence of the composite had not com-
promised the osmotic status of the DMEM in relation to
cell health, but also to recognise that synthetic HA con-
tains high concentrations of calcium phosphate that could
be released from the material into the external media (e.g.,
by degradation of the material and/or dissolution). Table 3
shows that the concentration of calcium in the media was
significantly lower than the negative control, confirming
that there was no dissolution of the composite; but in fact,
calcium and phosphorus have been adsorbed from the
DMEM, most likely for apatite nucleation. Kokubo et al,
have shown apatite nucleation and growth of HA in
Simulated Body Fluid (SBF) at physiologic temperature
and pH.42 However, the decreasing concentration of cal-
cium in the DMEM observed here was modest and the
total Ca concentrations remained in the sub-mmol/L range
(Table 3). It was not limiting cell growth or health as
confirmed by the normal cell morphology (Figure 3), as
well as the presence of expected enzyme activities (ALP
and LDH activity, Figure 4). Indeed, leaky cells would be
vulnerable to Ca-overload and cell death from a massive
inward Ca gradient (the intracellular free Ca2+ concentra-
tion is around 0.1 µmol/L in osteoblast43), but this was not
observed. However, compared to the HA alone treatment,
some of the cell homogenates from the composites showed
a higher total Ca concentration (Table 3). This can be
interpreted as physiological, where the cells are storing
more total intracellular Ca consistent with their role in
mineralisation of bone. Similar to calcium, significantly
higher quantities of phosphorus were observed in the cell
homogenate of the composites suggesting that the osteo-
blasts were reserving calcium and phosphorus for the
mineralization process. The observations on cell homoge-
nates are also corroborated by the reduction of phosphorus
in the external media (Table 3).
The concentrations of sodium and potassium in the
external media were in the normal range (Table 3). Since
sodium makes most of the osmotic content of the media,
any changes in the cell homogenates are not likely to be
explained by osmotic stress such as loss of volume control
(cell swelling not observed), and in any case, the data are
normalised to cell protein. Homogenate sodium and potas-
sium concentrations are rarely measured from osteoblasts,
but they are broadly similar to homogenates of mammalian
cells with nanomaterials (e.g.,34). Interestingly, the HA
alone treatment did have a lower total sodium concentra-
tion in the homogenate compared to all other treatments
(Table 3). This is not likely due to Ca/Na exchange activity
on the cell membrane causing Na efflux from the cells,44
because the homogenate Ca was unchanged in this treat-
ment. The homogenate potassium concentration also did
not change in this treatment. The effect of the coatings on
electrolyte homeostasis needs further investigation.
In addition to normal cell morphology (Figure 4) and the
electrolyte concentrations in the cell homogenates, the bio-
compatibility of the composites was also assessed by measur-
ing the LDH and ALP activity of the cells (Figure 5). Cell
viability was confirmed by the absence of LDH leak into the
external media. This is a well-established viability marker34
and the absence of leak of this cytosolic enzyme into external
media shows that cell membranes are intact (i.e., not leaking).
The absence of cumulative increases in LDH activity in the
media also would indicate that there are no dead cells releasing
their contents (i.e., that cell are alive and healthy). The cumu-
lative LDH leak into the external media was small
(<0.1 µmol/L, Figure 5) and a typical background for cell
culture (e.g.,34); suggesting the cells were healthy without
membrane damage. A modest LDH activity was detected
inside the cells (the cell homogenates, Figure 5), as would be
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expected,45 but the absence of an elevated LDH activity in the
homogenates also indicated that the cells were not under
metabolic stress (i.e., not using anaerobic metabolism).
Alkaline phosphatase activity was also measured (Figure 5B)
and the values for the controls (about 60 nmol/mg protein/min)
are broadly similar to those reported for osteoblasts (e.g.,46).
However, the ALP activity showed some small, but statisti-
cally significant decreases in the presence of the composites
(Figure 5B) which suggests that, although the cells were
proliferated, the expression of ALP was not keeping up; and
so some growth dilution of ALP activity may have occurred.
The absence of large increases in ALP activity is not surprising
in the seven-day duration of the current experiment as the cells
were still relatively immature, and ALP induction occurs later
on in the cell differentiation process.47 Nevertheless, the pre-




This study successfully synthesised HA-MWCNTs com-
posites and then demonstrated that healthy cells with
normal morphology, electrolyte composition and enzyme
activities could be grown on the materials over seven
Table 3 The Total Concentration Of The Electrolytes, Na+, K+, Ca2+, P And Mg2+ In The Media After Exposing The Osteoblasts To
The Composites For 7 Days And From The Cell Homogenates***
Electrolyte Concentration
(mmol/L)
Treatment Exposure Time (Days) Cell Homogenate
(µmol/mg Cell Protein)
Day 1 Day 4 Day 7
Sodium Blank 113 ± 0.1a 191 ± 0.2a 172 ± 0.1a 141 ± 7a
HA 180 ± 0.2b 177 ± 0.3a 124 ± 0.2ab 77 ± 12.0b
p-MWCNTs-PVA 103 ± 0.2a 138 ± 0.3ab 103 ± 0.2b 181 ± 24ac
f-MWCNTs-PVA 122 ± 0.1a 105 ± 0.05b 130 ± 0.1ab 168 ± 30a
p-MWCNTs-HTAB 110 ± 0.3a 170 ± 0.1ab 121 ± 0.3ab 231 ± 18c
f-MWCNTs-HTAB 103 ± 0.2a 142 ± 0.1ab 135 ± 0.2ab 200 ± 26ac
Potassium Blank 7.5 ± 0.6a 12.5 ± 1.3a 8.4 ± 1.4a 45 ± 1a
HA 7.1 ± 1a 9.8 ± 1.2ab 5.6 ± 0.5b 61 ± 11ab
p-MWCNTs-PVA 6.5 ± 0.2a 9.2 ± 2ab 5.1 ± 0.7b 88 ± 15b
f-MWCNTs-PVA 7.5 ± 0.2a 7 ± 1b 6.5 ± 0.7ab 53 ± 10a
p-MWCNTs-HTAB 6.5 ± 0.3a 11.1 ± 1.6a 6 ± 0.6ab 61 ± 10ab
f-MWCNTs-HTAB 6.7 ± 0.4a 9.1 ± 0.8ab 6.7 ± 0.8ab 52 ± 6a
Calcium Blank 1 ± 0.08a 1.69 ± 0.18a 1.33 ± 0.23a 17 ± 1a
HA 0.8 ± 0.1abc 0.85 ± 0.12b 0.13 ± 0.05bd 17 ± 1a
p-MWCNTs-PVA 0.5 ± 0.1bc 0.16 ± 0.06c 0.32 ± 0.16bcd 21 ± 5b
f-MWCNTs-PVA 1 ± 0.18ac 0.23 ± 0.07c 0.33 ± 0.07bcd 25 ± 3bc
p-MWCNTs-HTAB 0.57 ± 0.14bc 0.25 ± 0.04c 0.61 ± 0.16c 30 ± 4c
f-MWCNTs-HTAB 0.74 ± 0.11abc 0.08 ± 0.03c 0.06 ± 0.01bd 17 ± 1a
Phosphorus Blank 1.29 ± 0.11a 1.89 ± 0.22a 1.29 ± 0.11a 6.3 ± 1a
HA 2.14 ± 0.21b 2 ± 0.34ac 2.14 ± 0.21b 32 ± 4b
p-MWCNTs-PVA 1.32 ± 0.24a 1.27 ± 0.30bd 1.32 ± 0.24ab 45.1 ± 8c
f-MWCNTs-PVA 1 ± 0.17a 0.5 ± 0.05bd 1 ± 0.17abc 27.2 ± 5b
p-MWCNTs-HTAB 1.13 ± 0.36a 0.53 ± 0.10bd 1.13 ± 0.36cb 33.6 ± 7b
f-MWCNTs-HTAB 1.26 ± 0.21a 0.77 ± 0.10b 1.26 ± 0.21abc 26.6 ± 3 b
Magnesium Blank 1 ± 0.08a 1.56 ± 0.17a 1.26 ± 0.22a 0.86 ± 0.08a
HA 0.05 ± 0.01b 0.05 ± 0.01b 0.02 ± 0.004b 0.85 ± 0.06a
p-MWCNTs-PVA 0.05 ± 0.004b 0.04 ± 0.01b 0.04 ± 0.01b 1.26 ± 0.1a
f-MWCNTs-PVA 0.06 ± 0.01b 0.03 ± 0.01b 0.03 ± 0.01b 1.87 ± 0.2b
p-MWCNTs-HTAB 0.05 ± 0.01b 0.06 ± 0.01b 0.03 ± 0.003b 1.71 ± 0.1b
f-MWCNTs-HTAB 0.08 ± 0.01b 0.02 ± 0.002b 0.02 ± 0.003b 1.2 ± 0.1a
Notes: ***Data are expressed as mean ± S.E.M (n = 6 for each treatment). Different letters a, b, c, d are statistically different from each other within the column and within
electrolyte (one-way ANOVA or Kruskal–Wallis test, P <0.05).
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days. The study also shows that surfactants play a cru-
cial role in determining the structure of the HA crystals
and that the presence of MWCNTs had at least doubled
the strength of the composites, with PVA surfactant
proving the best coverage of HA over the composite
material and the p-MWCNTs PVA composite the stron-
gest material. All of the composites showed biocompat-
ibility in that overt toxicity to osteoblast cells was not
observed. However, of the composites examined, the f-
MWCNTs HTAB was considered the most biocompati-
ble with osteoblast cells as they had comparatively
lower LDH activity release in the media and higher
ALP activity in cell homogenate. These in vitro studies
are a first step towards meeting the criteria for an
acceptable nanomedicine or nanomaterial-containing
implant for clinical use.48,49 This study shows the f-
MWCNTs HTAB composite to be stronger than HA
alone (i.e., better than the implant materials used now)
and biocompatible, suggesting that it may at least be
safe for bone cells in the short term. In terms of
mechanical strengths, it is in line with callous bones
with a compressive strength above 20 MPa and tensile
strength 6–7 MPa. Therefore, this material can poten-
tially be used as dental or small bone graft. It will need
further improvement in mechanical strength to be used
as a load-bearing cortical bone replacement. Further
research also is needed to demonstrate the biocompat-
ibility of the composites over longer time scales (e.g.,
several weeks) and then in vivo with an animal model
before trials can begin with patients.
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